LOM
TEVA icon

Loeb Offshore Management’s Teva Pharmaceuticals TEVA Stock Holding History

Loeb Offshore Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-48,982
Closed -$2.57M – 171
2014
Q2 		$2.57M Sell
48,982
-71,721
-59% -$3.67M 0.45% 55
2014
Q1 		$6.38M Buy
120,703
+3,697
+3% +$171K 1.82% 14
2013
Q4 		$4.69M Buy
+117,006
New +$4.61M 1.3% 18

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loeb Offshore Management's TEVA Position: Q3 2014 in Review

Loeb Offshore Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2014, closing a stake of 48,982 shares — an estimated $2.57M sold.

Loeb Offshore Management first reported a position in TEVA in Q4 2013 and held it in 3 quarters. The position peaked at $6.38M in Q1 2014. 772 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

  • Loeb Offshore Management reported no remaining Teva Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Loeb Offshore Management sold 48,982 Teva Pharmaceuticals shares in Q3 2014, an estimated $2.57M.
  • Loeb Offshore Management first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 3 quarters.
  • Loeb Offshore Management's Teva Pharmaceuticals position peaked at $6.38M in Q1 2014.
  • 772 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2014.

Based on Loeb Offshore Management's 13F filing for Q3 2014, filed 14 Nov 2014.